Harris Todd 4

What Happened

• Harris Todd, President & CEO and a director of Tyra Biosciences (TYRA), acquired 1,463 shares on 2026-03-13 at $9.13 per share, a total acquisition value of $13,356. The transaction is reported on a Form 4 as an acquisition (code A) and was completed under the issuer’s 2021 Employee Stock Purchase Plan (ESPP).

Key Details

• Transaction date and price: 2026-03-13 at $9.13 per share.
• Shares acquired: 1,463; total value: $13,356.
• Method: Purchased under the Issuer’s 2021 Employee Stock Purchase Plan (footnote F1).
• Filing date: Form 4 filed 2026-03-17 (filed within the SEC’s reporting deadline for this transaction date).
• Shares owned after transaction: Not specified in the information provided.

Context

• This was an ESPP purchase (employee plan acquisition), a routine way for employees and executives to buy company stock—typically through payroll deductions and sometimes at a discount—rather than an open-market trade or option exercise. Such purchases are informational but do not by themselves prove any particular outlook by the insider.